bi 144807
Small moleculeexperimental
Clinical trial activity
5 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2011 (NCT01480648)
Timeline
Indications
Mechanism of action
- C-C chemokine receptor type 3ANTAGONIST
CCR3 antagonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- bi 144807
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02121522 | Phase 2 | Jun 1, 2014 | Boehringer Ingelheim |
| NCT01897597 | Phase 1 | Jul 1, 2013 | Boehringer Ingelheim |
| NCT01707940 | Phase 1 | Oct 1, 2012 | Boehringer Ingelheim |
| NCT01651598 | Phase 1 | Jul 1, 2012 | Boehringer Ingelheim |
| NCT01480648 | Phase 1 | Nov 1, 2011 | Boehringer Ingelheim |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Boehringer Ingelheim | For profit | 5 | 5 | 2 | 2011 |
1 organizations
Page 1 / 1